ProQR Therapeutics (PRQR) Retained Earnings (2021 - 2025)

ProQR Therapeutics (PRQR) has disclosed Retained Earnings for 5 consecutive years, with $33.4 million as the latest value for Q4 2025.

  • Quarterly Retained Earnings rose 107.32% to $33.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $33.4 million through Dec 2025, up 107.32% year-over-year, with the annual reading at $33.4 million for FY2025, 107.32% up from the prior year.
  • Retained Earnings hit $33.4 million in Q4 2025 for ProQR Therapeutics, up from -$456.5 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $33.4 million in Q4 2025 to a low of -$456.5 million in Q4 2024.
  • Historically, Retained Earnings has averaged -$237.4 million across 5 years, with a median of -$363.5 million in 2021.
  • Biggest five-year swings in Retained Earnings: soared 108.49% in 2022 and later tumbled 1496.81% in 2023.
  • Year by year, Retained Earnings stood at -$363.5 million in 2021, then skyrocketed by 108.49% to $30.9 million in 2022, then crashed by 1496.81% to -$431.3 million in 2023, then fell by 5.84% to -$456.5 million in 2024, then surged by 107.32% to $33.4 million in 2025.
  • Business Quant data shows Retained Earnings for PRQR at $33.4 million in Q4 2025, -$456.5 million in Q4 2024, and -$431.3 million in Q4 2023.